Brii Biosciences Limited (HKG:2137)
1.560
+0.070 (4.70%)
Feb 13, 2026, 4:08 PM HKT
Brii Biosciences Revenue
Brii Biosciences had revenue of 993.00K CNY in the half year ending June 30, 2025, a decrease of -97.52%. This brings the company's revenue in the last twelve months to 28.77M, down -24.18% year-over-year. In the year 2024, Brii Biosciences had annual revenue of 49.94M, down -10.65%.
Revenue (ttm)
28.77M CNY
Revenue Growth
-24.18%
P/S Ratio
35.70
Revenue / Employee
299.73K CNY
Employees
96
Market Cap
1.13B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 49.94M | -5.96M | -10.65% |
| Dec 31, 2023 | 55.89M | -66.39M | -54.29% |
| Dec 31, 2022 | 122.28M | 29.74M | 32.13% |
| Dec 31, 2021 | 92.54M | 10.32M | 12.56% |
| Dec 31, 2020 | 82.22M | 62.02M | 307.10% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| 3D Medicines | 491.34M |
| JW (Cayman) Therapeutics Co. | 194.77M |
| Wuhan YZY Biopharma | 163.65M |
| Beijing Biostar Pharmaceuticals | 58.66M |
| Kintor Pharmaceutical | 12.04M |
| Transcenta Holding | 10.31M |
| Sirnaomics | 7.45M |
| Sunho Biologics | 18.63K |